Skip to Main Content

Author Details

Fang-I Chu
David Geffen School of Medicine, University of California los angeles
2018
39
12
PMIDPaper TitleJournal TitlePublished Year
37141981High Recurrence for HPV-Positive Oropharyngeal Cancer With Neoadjuvant Radiation Therapy to Gross Disease Plus Immunotherapy: Analysis From a Prospective Phase Ib/II Clinical Trial.Int J Radiat Oncol Biol Phys2023
37588769Estimating Time-Varying Treatment Switching Effect Using Accelerated Failure Time Model with Application to Vascular Access for Hemodialysis.Commun Stat Theory Methods2023
37568732Predicting Overall Survival for Patients with Malignant Mesothelioma Following Radiotherapy via Interpretable Machine Learning.Cancers (Basel)2023
37279645M2 isoform of pyruvate kinase rewires glucose metabolism during radiation therapy to promote an antioxidant response and glioblastoma radioresistance.Neuro Oncol2023
34107296Ablative radiotherapy for liver tumors using stereotactic MRI-guidance: A prospective phase I trial.Radiother Oncol2022
35694034Characterizing Twitter Influencers in Radiation Oncology.Adv Radiat Oncol2022
35934601Local Failure Events in Prostate Cancer Treated with Radiotherapy: A Pooled Analysis of 18 Randomized Trials from the Meta-analysis of Randomized Trials in Cancer of the Prostate Consortium (LEVIATHAN).Eur Urol2022
36216758Current Practice Patterns in Locally Advanced Rectal Cancer at Academic Institutions: A National Survey Among Radiation Oncologists, Medical Oncologists, and Colorectal Surgeons.Clin Colorectal Cancer2022
34725193Radiosensitizing Pancreatic Cancer via Effective Autophagy Inhibition.Mol Cancer Ther2022
31411981Underutilization of Androgen Deprivation Therapy with External Beam Radiotherapy in Men with High-grade Prostate Cancer.Eur Urol Oncol2021
33793602Characterizing and quantifying the temporal relationship between structural and functional change in glaucoma.PLoS One2021
33599771Assessment of Toxic Effects Associated With Dose-Fractionated Radiotherapy Among Patients With Cancer and Comorbid Collagen Vascular Disease.JAMA Netw Open2021
33898868Dosimetric Quality of Online Adapted Pancreatic Cancer Treatment Plans on an MRI-Guided Radiation Therapy System.Adv Radiat Oncol2021
34826815Linear accelerator-based radiosurgery for trigeminal neuralgia: comparative outcomes of frame-based and mask-based techniques.J Neurosurg2021
34076341National variation in the delivery of radiation oncology procedures in the non-facility-based setting.Cancer Med2021
34288538Clinical outcomes of stereotactic magnetic resonance image-guided adaptive radiotherapy for primary and metastatic tumors in the abdomen and pelvis.Cancer Med2021
33417480Provider-Level Variation in Treatment Planning of Radiation Oncology Procedures in the United States.JCO Oncol Pract2021
32647353The intraprostatic immune environment after stereotactic body radiotherapy is dominated by myeloid cells.Prostate Cancer Prostatic Dis2021
32141219Delayed conversion from central venous catheter to non-catheter hemodialysis access associates with an increased risk of death: A retrospective cohort study based on data from a large dialysis provider.Hemodial Int2020
33898771Dosimetric impact from cardiac motion to heart substructures in thoracic cancer patients treated with a magnetic resonance guided radiotherapy system.Phys Imaging Radiat Oncol2020
32054730A Phase II Trial of 5-Day Neoadjuvant Radiotherapy for Patients with High-Risk Primary Soft Tissue Sarcoma.Clin Cancer Res2020
31718822Local Failure and Survival After Definitive Radiotherapy for Aggressive Prostate Cancer: An Individual Patient-level Meta-analysis of Six Randomized Trials.Eur Urol2020
33305096Clinical Development and Evaluation of Megavoltage Topogram for Fast Patient Alignment on Helical Tomotherapy.Adv Radiat Oncol2020
30342179Impact of Open Access to Physician Notes on Radiation Oncology Patients: Results from an Exploratory Survey.Pract Radiat Oncol2019
31673667Association between Long-Term Second Malignancy Risk and Radiation: A Comprehensive Analysis of the Entire Surveillance, Epidemiology, and End Results Database (1973-2014).Adv Radiat Oncol2019
32529134Gantry-Mounted Linear Accelerator-Based Stereotactic Body Radiation Therapy for Low- and Intermediate-Risk Prostate Cancer.Adv Radiat Oncol2019
31420022Non-contrast-enhanced magnetic resonance angiography of facial arteries for pre-operative evaluation of vascularized submental lymph node flaps.BMC Med Imaging2019
31276777Multi-Institutional Analysis of Prostate-Specific Antigen Kinetics After Stereotactic Body Radiation Therapy.Int J Radiat Oncol Biol Phys2019
30735235Long-term Outcomes of Stereotactic Body Radiotherapy for Low-Risk and Intermediate-Risk Prostate Cancer.JAMA Netw Open2019
31108142Testosterone Levels and Sexual Quality of Life After Stereotactic Body Radiation Therapy for Prostate Cancer: A Multi-Institutional Analysis of Prospective Trials.Int J Radiat Oncol Biol Phys2019
31102690Fast, Low-Dose Megavoltage-Topogram Localization on TomoTherapy: Initial Clinical Experience With Mesothelioma Patients.Pract Radiat Oncol2019
30901047Assessment of Differences in Clinical Activity and Medicare Payments Among Female and Male Radiation Oncologists.JAMA Netw Open2019
30681710Evaluation of Sex Distribution of Industry Payments Among Radiation Oncologists.JAMA Netw Open2019
29242398Impact of <sup>68</sup>Ga-PSMA-11 PET/CT on the Management of Prostate Cancer Patients with Biochemical Recurrence.J Nucl Med2018
29123013<sup>68</sup>Ga-PSMA-11 PET/CT Mapping of Prostate Cancer Biochemical Recurrence After Radical Prostatectomy in 270 Patients with a PSA Level of Less Than 1.0 ng/mL: Impact on Salvage Radiotherapy Planning.J Nucl Med2018
29712667Restructuring of the Gut Microbiome by Intermittent Fasting Prevents Retinopathy and Prolongs Survival in db/db Mice.Diabetes2018
29723304Associations between structure and function are different in healthy and glaucomatous eyes.PLoS One2018
29954680Comparing Outcomes of Patients With Early-Stage Non-Small-Cell Lung Cancer Treated With Stereotactic Body Radiotherapy Based on Frailty Status.Clin Lung Cancer2018
30208044Improving wellbeing and reducing future world population.PLoS One2018
  • 1 - 39 of 39

Recommended Authors

Michael A Golafshar
Mayo Clinic
Career Start Year 2018
Number of shared co-authors 0
Holly E Hartman
Case Western Reserve University
Career Start Year 2018
Number of shared co-authors 35
Katherine Lajkosz
Princess Margaret Hospital
Career Start Year 2017
Number of shared co-authors 1
Erqi L Pollom
Stanford University
Career Start Year 2014
Number of shared co-authors 25
Rachel M Glicksman
University of Toronto, Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 24
Andrew Warner
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 4
Darlene Veruttipong
Stanford University
Career Start Year 2012
Number of shared co-authors 11
Christine Massey
Princess Margaret Cancer Centre
Career Start Year 2010
Number of shared co-authors 1
Chen Hu
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 8
Danielle Rodin
Princess Margaret Cancer Centre, University of Toronto
Career Start Year 2009
Number of shared co-authors 4
Brian P Hobbs
Dell Medical School, University of Texas at Austin
Career Start Year 2008
Number of shared co-authors 1
Jure Murgic
University Hospital Center Sestre Milosrdnice
Career Start Year 2008
Number of shared co-authors 6
Rahul D Tendulkar
Taussig Cancer Institute, Cleveland Clinic
Career Start Year 2006
Number of shared co-authors 30
Sunita Ghosh
Cross Cancer Institute
Career Start Year 2006
Number of shared co-authors 1
Himanshu Nagar
New York-Presbyterian Hospital, Weill Cornell Medical Center
Career Start Year 2005
Number of shared co-authors 14
Eyad Abu-Isa
Ascension Providence Hospital
Career Start Year 2005
Number of shared co-authors 32
Chaya S Moskowitz
Memorial Sloan Kettering Cancer Center.
Career Start Year 2002
Number of shared co-authors 1
Neha Vapiwala
Abramson Cancer Center, University of Pennsylvania
Career Start Year 2001
Number of shared co-authors 24
Clifton D Fuller
The University of Texas MD Anderson Cancer Center
Career Start Year 2001
Number of shared co-authors 9
Amit Bahl
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year 2001
Number of shared co-authors 6
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year 2001
Number of shared co-authors 3
Gregory R Pond
Juravinski Hospital and Cancer Centre, Escarpment Cancer Research Institute
Career Start Year 2001
Number of shared co-authors 3
Chiaojung Jillian Tsai
Memorial Sloan Kettering Cancer Center
Career Start Year 2000
Number of shared co-authors 2
David A Palma
University of Western Ontario
Career Start Year 2000
Number of shared co-authors 5
Andre Dekker
Maastricht University Medical Centre
Career Start Year 1998
Number of shared co-authors 5
Steve E Braunstein
University of California san francisco
Career Start Year 1998
Number of shared co-authors 3
Alexandra L Hanlon
Virginia Tech
Career Start Year 1994
Number of shared co-authors 5
Jonathan D Tward
Huntsman Cancer Institute, University of Utah
Career Start Year 1994
Number of shared co-authors 32
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year 1994
Number of shared co-authors 5
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 5

Collaborators

Michael L Steinberg
University of California los angeles
Co-authored papers 24
Amar U Kishan
University of California los angeles
Co-authored papers 13
Nicholas G Nickols
University of California, Veteran Affairs Greater Los Angeles Healthcare System
Co-authored papers 10
Christopher R King
University of California los angeles
Co-authored papers 9
Patrick A Kupelian
university of california los angeles Medical Center
Co-authored papers 8
Minsong Cao
University of California Los Angeles
Co-authored papers 7
Daniel A Low
University of California los angeles
Co-authored papers 6
Robert E Reiter
David Geffen School of Medicine at university of california los angeles
Co-authored papers 5
Luca F Valle
University of California los angeles
Co-authored papers 5
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Co-authored papers 5
Daniel E Spratt
University Hospitals Seidman Cancer Center, Case Western Reserve University
Co-authored papers 5
Audrey Dang
Tulane University School of Medicine
Co-authored papers 4
Yingli Yang
Ruijin Hospital
Co-authored papers 3
Chenyang Wang
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Co-authored papers 3
Nzhde Agazaryan
University of California los angeles
Co-authored papers 3
Nima Aghdam
Beth Israel Deaconess Medical Center, Harvard Medical School
Co-authored papers 3
Sean P Collins
Vanderbilt University School of Medicine
Co-authored papers 3
David Elashoff
David Geffen School of Medicine at University of California los angeles
Co-authored papers 3
Ye Yuan
Southwest Hospital, Army Medical University
Co-authored papers 3
Constantine A Mantz
University of Chicago
Co-authored papers 3
Michael Xiang
University of California los angeles
Co-authored papers 2
Ting Martin Ma
University of Washington
Co-authored papers 2
Kiri A Sandler
Oregon Health and Science University
Co-authored papers 2
David Shabsovich
university of california los angeles Medical Center
Co-authored papers 2
Sandy T Liu
David Geffen School of Medicine at university of california los angeles
Co-authored papers 2
Albert J Chang
University of California Los Angeles
Co-authored papers 2
Mark K Buyyounouski
Stanford University
Co-authored papers 2
Tahmineh Romero
David Geffen School of Medicine at university of california los angeles
Co-authored papers 2
Drew Moghanaki
University of California Los Angeles
Co-authored papers 2
Andrew Loblaw
Princess Margaret Hospital, University of Toronto
Co-authored papers 2
Release 1.2